Compare · BDX vs SKIN
BDX vs SKIN
Side-by-side comparison of Becton Dickinson and Company (BDX) and SkinHealth Systems Inc. (SKIN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BDX and SKIN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- BDX is the larger of the two at $51.69B, about 611.0x SKIN ($84.6M).
- BDX has been more active in the news (10 items in the past 4 weeks vs 5 for SKIN).
- Both have 25 recent analyst ratings on file.
- Company
- Becton Dickinson and Company
- SkinHealth Systems Inc.
- Price
- $189.79-0.43%
- $0.67-1.56%
- Market cap
- $51.69B
- $84.6M
- 1M return
- +19.45%
- -
- 1Y return
- -2.22%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 10
- 5
- Recent ratings
- 25
- 25
Becton Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps, dedicated disposables, IV fluids, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
SkinHealth Systems Inc.
Edge Systems, LLC designs, develops, manufactures, markets, and sells aesthetic technologies and products. It offers hydradermabrasion system that enhances the skin to cleanse, exfoliate, extract, and hydrate simultaneously; Hydraglucan Intense Hydration Booster, a customization for the HydraFacial treatment exfoliates the skin by improving cell renewal and delivers ingredients, including hyaluronic acid, glucan, and betaine to hydrate the skin and provide anti-aging benefits; HydraFacial Daily Essentials, which provides detoxification, rejuvenation, and protection of skin; crystal microdermabrasion systems; and light emitting diode systems. The company also provides HydraFacial CONNECT platform, a three-level industry certification program that will advance aesthetic professionals' skills and give them recognition, respect, and rewards; and system surgical smoke evacuators that vacuums the plume created by laser and electrocautery treatments, such as hair removal, tattoo removal, erbium, and veterinary procedures. Its system surgical smoke evacuators are used by hospitals, plastic surgeons, cosmetic surgeons, OB/GYN, veterinarians, and others. In addition, it offers marketing support services. Its products are distributed worldwide through its sales network. The company was founded in 1997 and is based in Signal Hill, California with a location in Long Beach, California.
Latest BDX
- EVP, Chief Revenue Officer Feld Michael covered exercise/tax liability with 1,049 shares, decreasing direct ownership by 5% to 19,885 units (SEC Form 4) (for withholding tax)
- BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire
- Chairman, CEO and President Polen Thomas E Jr exercised 43,278 shares at a strike of $167.25, returned $7,238,310 worth of shares to the company (39,126 units at $185.00) and sold $768,120 worth of shares (4,152 units at $185.00) as part of a pre-agreed trading plan (SEC Form 4)
- EVP and President, EMEA Goette Roland sold $440,888 worth of shares (2,438 units at $180.84), decreasing direct ownership by 14% to 14,856 units (SEC Form 4)
- BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial
- SEC Form 4 filed by Director Huffines Robert Luther
- SEC Form 4 filed by Director Byington Carrie L
- SEC Form 10-Q filed by Becton Dickinson and Company
- Becton Dickinson and Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- BD Reports Third Quarter Fiscal 2026 Financial Results
Latest SKIN
- Chief Financial Officer Monahan Michael P. covered exercise/tax liability with 32,357 shares, decreasing direct ownership by 2% to 1,955,280 units (SEC Form 4) (for tax liability)
- SEC Form DEFA14A filed by SkinHealth Systems Inc.
- SEC Form DEF 14A filed by SkinHealth Systems Inc.
- SEC Form 10-Q filed by SkinHealth Systems Inc.
- SkinHealth Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form PRE 14A filed by SkinHealth Systems Inc.
- SkinHealth Systems to Report Second Quarter 2026 Financial Results on August 6, 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by SkinHealth Systems Inc.
- SkinStylus® Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types
- SkinHealth Systems Inc. filed SEC Form 8-K: Other Events